Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03547869 · ClinicalTrials.gov registry record · NA
Transcranial Direct Current Stimulation for Pain Treatment in Gulf War Illness.
A NA study, sponsored by The University of Texas at Dallas.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03547869: Clinical Trial NA study, sponsored by The University of Texas at Dallas.
NCT03547869 is a NA study that was terminated before completion, run by The University of Texas at Dallas. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03547869, a NA study, was terminated before completion, sponsored by The University of Texas at Dallas.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The goal of this study is to investigate long-term modulation of pain pathways leading to a suppression of pain symptoms in Gulf War Illness patients by applying transcranial direct current stimulation.
Primary Outcome
Pain symptoms changes will be assessed by a Visual Analogue Scale for pain and the results will be compared between the two groups (active tDCS and sham tDCS) to study any possible differences occurring throughout the sessions. 0 no pain - 100 cm maximum pain you can imagine.
Interventions
- DEVICE Sham tDCS
- DEVICE Active tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-03-12 |
| Est. Completion | 2023-01-25 |
| Phase | NA |
Why NCT03547869 stopped before completion
NCT03547869 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham tDCS is the first listed.
NCT03547869 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03547869 about?
NCT03547869 is a clinical study titled "Transcranial Direct Current Stimulation for Pain Treatment in Gulf War Illness.". The goal of this study is to investigate long-term modulation of pain pathways leading to a suppression of pain symptoms in Gulf War Illness patients by applying transcranial direct current stimulation.
What is the current status of trial NCT03547869?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2018-03-12. Estimated completion is 2023-01-25.
What interventions are being tested in trial NCT03547869?
The interventions under investigation include: Sham tDCS (DEVICE), Active tDCS (DEVICE).
Who is sponsoring clinical trial NCT03547869?
This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03547869's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI